Clinical guidelines and details on access routes for plant-based medicine products can be found in the source article provided by the TGA. To view the article, click the link below.
Accessing plant-based medicine for a patient
If you decide that ‘unapproved’ plant-based medicine products are clinically appropriate for your patient, there are four access pathways:
- Authorised Prescriber – Established History of Use pathway
- Authorised Prescriber – Standard pathway
- SAS Category A notification pathway
- SAS Category B application pathway
Information about studies provided by Cannatrek on this website is for education purposes only. It is not a substitute for professional health advice. Nothing contained in this site, or any external site linked to by Cannatrek, is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional’s advice. Cannatrek does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information provided on this website, or any external site linked to by Cannatrek. Further, Cannatrek accepts no responsibility for material contained in a website that is linked to this site. It is the responsibility of the user to make their own decisions about the accuracy, currency, reliability and correctness of information contained in linked external websites.